AGL 38.70 Increased By ▲ 0.20 (0.52%)
AIRLINK 137.88 Increased By ▲ 0.99 (0.72%)
BOP 5.43 Increased By ▲ 0.03 (0.56%)
CNERGY 3.78 No Change ▼ 0.00 (0%)
DCL 7.74 Decreased By ▼ -0.14 (-1.78%)
DFML 45.62 Decreased By ▼ -0.18 (-0.39%)
DGKC 80.50 Increased By ▲ 0.15 (0.19%)
FCCL 29.55 Increased By ▲ 0.65 (2.25%)
FFBL 55.80 Decreased By ▼ -1.20 (-2.11%)
FFL 9.09 Decreased By ▼ -0.34 (-3.61%)
HUBC 105.60 Increased By ▲ 1.86 (1.79%)
HUMNL 14.05 Increased By ▲ 0.08 (0.57%)
KEL 4.30 Increased By ▲ 0.58 (15.59%)
KOSM 8.23 Decreased By ▼ -0.01 (-0.12%)
MLCF 37.98 Increased By ▲ 0.58 (1.55%)
NBP 69.23 Increased By ▲ 0.83 (1.21%)
OGDC 167.00 Increased By ▲ 0.40 (0.24%)
PAEL 25.20 Increased By ▲ 0.19 (0.76%)
PIBTL 6.78 Decreased By ▼ -0.27 (-3.83%)
PPL 130.35 Increased By ▲ 0.99 (0.77%)
PRL 23.76 Increased By ▲ 0.09 (0.38%)
PTC 15.70 Decreased By ▼ -0.15 (-0.95%)
SEARL 61.48 Increased By ▲ 0.68 (1.12%)
TELE 7.04 Increased By ▲ 0.03 (0.43%)
TOMCL 36.10 Increased By ▲ 0.21 (0.59%)
TPLP 7.81 Decreased By ▼ -0.05 (-0.64%)
TREET 15.15 Increased By ▲ 0.09 (0.6%)
TRG 44.89 Decreased By ▼ -0.01 (-0.02%)
UNITY 25.51 Increased By ▲ 0.11 (0.43%)
WTL 1.27 Increased By ▲ 0.04 (3.25%)
BR100 9,223 Increased By 22.5 (0.24%)
BR30 27,766 Increased By 205.8 (0.75%)
KSE100 86,467 Increased By 409.1 (0.48%)
KSE30 27,163 Increased By 118.7 (0.44%)

It is not at all that prescribing the drugs by their market names is wrong. There is something to think about the fact whether it would be more transparent and in the benefits of the patients to write the drugs by the brand names. There are plenty of renowned pharmaceutical companies that charge the costly and hefty amount for the same drug which the other new smaller scale pharmaceutical companies are selling for less. The point is that why there is a difference in drugs when the same chemical is being sold in different packings.

Since the issue we are discussing is very delicate and believe the whole pharmaceutical world would defend writing the medicines by the brand names. After all, for the pharmaceutical companies, it is their business. However, I am more concerned with the poor patients who have to run after the costly medicines just because their medical doctor has prescribed the brand name. I wish, there was a system to write the generic names to make it more cost-effective and time-effective for the poor and needy patients.

(Concluded)

Dr. Batool Hassan

B.Sc., BS (US), MBBS, PGD HCM, CHQP, RMP.

Email [email protected]

Copyright Business Recorder, 2021

Comments

Comments are closed.